HLA-C and neoplasm: DC-derived sEVs can carry whole tumor associated antigens (TAAs), TAA peptide-loaded MHC/HLA, and co-stimulatory signals significantly improving vaccination efficacy compared to whole tumor lysate vaccination (133).